Boltzmann Labs ^Company

Boltzmann Labs is a leading AI-powered drug discovery and protein engineering company revolutionizing the way scientists design and optimize molecules. Our advanced multi-agent Generative AI platform accelerates every stage of drug discovery, from target identification, lead optimization, and virtual screening to ADMET prediction and enzyme optimization. By combining computational chemistry, molecular docking, bioinformatics, and deep learning, Boltzmann Labs enables researchers, startups, and pharmaceutical companies to design better therapeutics faster and at lower cost. Whether it’s small-molecule design, enzyme stability improvement, or in-silico protein modeling, our tools empower innovation across the life sciences. With a mission to democratize in-silico R&D, Boltzmann Labs acts as your virtual research partner by delivering AI-driven precision, predictive accuracy, and end-to-end solutions for next-generation drug discovery.